{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:07:30Z","timestamp":1778724450139,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["912-03-033 2003"],"award-info":[{"award-number":["912-03-033 2003"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["RUL 99\/1992"],"award-info":[{"award-number":["RUL 99\/1992"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019926","name":"Netherlands Organization for Applied Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","award":["NHS 98.113"],"award-info":[{"award-number":["NHS 98.113"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.thromres.2026.109668","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:41:08Z","timestamp":1776440468000},"page":"109668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["C-reactive protein and risk of venous thromboembolism - results from the MEGA study"],"prefix":"10.1016","volume":"261","author":[{"given":"Eng Soo","family":"Yap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid K.","family":"Br\u00e6kkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem M.","family":"Lijfering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frits R.","family":"Rosendaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne C.","family":"Cannegieter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luuk J.J.","family":"Scheres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.thromres.2026.109668_bb0005","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1538-7836.2005.01415.x","article-title":"Venous thromboembolism: disease burden, outcomes and risk factors","volume":"3","author":"Heit","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"9159","key":"10.1016\/j.thromres.2026.109668_bb0010","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.thromres.2026.109668_bb0015","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1161\/ATVBAHA.109.198473","article-title":"C-reactive protein and risk of venous thromboembolism in the general population","volume":"30","author":"Zacho","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.thromres.2026.109668_bb0020","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1160\/TH11-09-0611","article-title":"Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review","volume":"107","author":"Tichelaar","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2026.109668_bb0025","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3324\/haematol.2017.186957","article-title":"C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study","volume":"103","author":"Grimnes","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.thromres.2026.109668_bb0030","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/s13018-020-02089-4","article-title":"Age over 65 years and high levels of C-reactive protein are associated with the risk of preoperative deep vein thrombosis following closed distal femur fractures: a prospective cohort study","volume":"15","author":"Zhang","year":"2020","journal-title":"J. Orthop. Surg. Res."},{"issue":"5","key":"10.1016\/j.thromres.2026.109668_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052627","article-title":"Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: a narrative review","volume":"22","author":"Galeano-Valle","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.thromres.2026.109668_bb0040","first-page":"615","article-title":"C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort","volume":"102","author":"Folsom","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109668_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3324\/haematol.2009.011866","article-title":"Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2)","volume":"95","author":"Quist-Paulsen","year":"2010","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.thromres.2026.109668_bb0050","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3324\/haematol.2010.034991","article-title":"High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study","volume":"96","author":"Hald","year":"2011","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.thromres.2026.109668_bb0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10654-017-0277-4","article-title":"Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence","volume":"32","author":"Kunutsor","year":"2017","journal-title":"Eur. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.thromres.2026.109668_bb0060","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9343(02)01345-1","article-title":"Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)","volume":"113","author":"Tsai","year":"2002","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.thromres.2026.109668_bb0065","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.ATV.21.5.731","article-title":"Elevated factor VIII levels and the risk of thrombosis","volume":"21","author":"Kamphuisen","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.thromres.2026.109668_bb0070","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1538-7836.2004.00773.x","article-title":"C-reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype-based analysis","volume":"2","author":"Zee","year":"2004","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2026.109668_bb0075","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1538-7836.2012.04828.x","article-title":"The relationship between body mass index, activated protein C resistance and risk of venous thrombosis","volume":"10","author":"Christiansen","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109668_bb0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/ATVBAHA.109.188920","article-title":"Anthropometric measures of obesity and risk of venous thromboembolism: the Tromso study","volume":"30","author":"Borch","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"19","key":"10.1016\/j.thromres.2026.109668_bb0085","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1161\/CIRCULATIONAHA.109.863241","article-title":"Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study","volume":"120","author":"Severinsen","year":"2009","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.thromres.2026.109668_bb0090","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults","volume":"282","author":"Visser","year":"1999","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2026.109668_bb0095","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0049-3848(15)50432-5","article-title":"The mechanisms of cancer-associated thrombosis","volume":"135","author":"Falanga","year":"2015","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2026.109668_bb0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.thromres.2026.109668_bb0105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.thromres.2026.109668_bb0110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10654-010-9475-z","article-title":"Experience with multiple control groups in a large population-based case-control study on genetic and environmental risk factors","volume":"25","author":"Pomp","year":"2010","journal-title":"Eur. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.thromres.2026.109668_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109668_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jth.14343","article-title":"High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor","volume":"17","author":"Rietveld","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"19","key":"10.1016\/j.thromres.2026.109668_bb0125","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2026.109668_bb0130","series-title":"Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)","first-page":"1549","author":"Timp","year":"2019"},{"key":"10.1016\/j.thromres.2026.109668_bb0135","series-title":"Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","first-page":"1538","author":"Kearon","year":"2016"},{"issue":"17","key":"10.1016\/j.thromres.2026.109668_bb0140","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1001\/jama.2009.565","article-title":"Microalbuminuria and risk of venous thromboembolism","volume":"301","author":"Mahmoodi","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.thromres.2026.109668_bb0145","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1055\/s-0037-1614553","article-title":"Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions","volume":"81","author":"Kamphuisen","year":"1999","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109668_bb0150","first-page":"668","article-title":"Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: a focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP)","volume":"102","author":"Luxembourg","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109668_bb0155","series-title":"StatPearls","article-title":"C Reactive Protein","author":"Nehring","year":"2024"},{"issue":"1","key":"10.1016\/j.thromres.2026.109668_bb0160","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jth.12043","article-title":"Risk of venous thrombosis in patients with major illnesses: results from the MEGA study","volume":"11","author":"Ocak","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109668_bb0165","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109668_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2009.954","article-title":"Genetic loci associated with C-reactive protein levels and risk of coronary heart disease","volume":"302","author":"Elliott","year":"2009","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.thromres.2026.109668_bb0175","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"359","author":"Zacho","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.thromres.2026.109668_bb0180","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/clc.23246","article-title":"Interleukin-1 blockade treatment decreasing cardiovascular risk","volume":"42","author":"Zheng","year":"2019","journal-title":"Clin. Cardiol."},{"issue":"18","key":"10.1016\/j.thromres.2026.109668_bb0185","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","article-title":"A randomized trial of rosuvastatin in the prevention of venous thromboembolism","volume":"360","author":"Glynn","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2026.109668_bb0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.thromres.2011.09.024","article-title":"The acute phase reaction explains only a part of initially elevated factor VIII:C levels: a prospective cohort study in patients with venous thrombosis","volume":"129","author":"Tichelaar","year":"2012","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2026.109668_bb0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613747","article-title":"High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism","volume":"83","author":"Kraaijenhagen","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109668_bb0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-0037-1613748","article-title":"Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response","volume":"83","author":"O\u2019Donnell","year":"2000","journal-title":"Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:08:50Z","timestamp":1778720930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"alternative-id":["S0049384826000873"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109668","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-reactive protein and risk of venous thromboembolism - results from the MEGA study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109668"}}